Showing results (1591-1600 of 1,755) with videos related to

Sort By:
Pageof 176
Expert Review of Hematology|December 23, 2022
Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathiesNuria Blazquez-Ramos, José A Romero-Garrido, Luis Gonzalez Del Valle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2021
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studiesMark W Skinner, Claude Négrier, Ido Paz-Priel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2020
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diaryAndreas Tiede, Santiago Bonanad, Amparo Santamaria, et al.
The New England Journal of Medicine|August 30, 2018
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without InhibitorsJohnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, et al.
Thrombosis and Haemostasis|April 17, 2015
Inhibitors in nonsevere haemophilia A: outcome and eradication strategiesAlice S van Velzen, Corien L Eckhardt, Daniel P Hart, et al.
Journal of Clinical Medicine|April 30, 2021
The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune ThrombocytopaeniaAndrés Ramírez-López, María Teresa Álvarez Román, Elena Monzón Manzano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminomaJ Aparicio, X García del Muro, P Maroto, et al.
Medicina (Kaunas, Lithuania)|April 3, 2021
Impact of COVID-19 Pandemic on Patients with Immune ThrombocytopaeniaMaría-Teresa Álvarez Román, Víctor Jiménez Yuste, Sara García Barcenilla, et al.
The Journal of Pathology|July 18, 2024
Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver diseaseMaría Ángeles Núñez-Sánchez, María Antonia Martínez-Sánchez, Marta Sierra-Cruz, et al.
Pageof 176